Philips and Paracelsus Clinics enter into 8-year strategic partnership
02 Marzo 2020 - 3:00AM
Philips and Paracelsus Clinics enter into 8-year strategic
partnership
March 2, 2020
Philips’ technology innovation, digitalization and AI-based
analytics drive continuous process of sustainable transformation
for Paracelsus Clinics
Amsterdam, the Netherlands & Osnabrück, Germany –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, and Paracelsus Clinics, today announced they have
entered into a strategic partnership for the next eight years. The
partnership is focused on continuous modernization of Paracelsus
Clinics’ medical imaging systems. Based on the evolving needs of
the hospital, the partnership will offer solutions that maximize
imaging system availability and standardize equipment operation,
leveraging digitalization and process optimization to realize
efficiency improvements while at the same time increasing
quality.
“Paracelsus is committed to providing integrated care close to
where people live in Germany,” said Dr. med. Dr. jur. Martin
Siebert, CEO of Paracelsus Clinics. “With Philips, we now have a
partner by our side who will support us in expanding this position
and strengthen our future viability through its strengths in
innovation and its digital competence. As an exclusive supplier,
Philips will take care of new and replacement imaging system
procurement, together with management and the training of our
employees. The scope of delivery includes CT, MRI, angiography,
X-ray and ultrasound systems. Philips offers the greatest possible
flexibility in designing a tailor-made equipment pool that matches
our changing requirements over time.”
“In addressing the challenges of the future, offering the latest
technological innovations is only the first step,” said Peter
Vullinghs, Senior Vice President, General Manager Philips GmbH
Market DACH. "In our strategic partnership with Paracelsus we want
to firmly anchor quality and efficiency as key success factors, not
only at the structural level but also at the process level. It’s
the only way we can achieve more together.”
“We were won over by the innovative concept for digitalization
that Philips offered,” said Florian Distler, Head of the
Procurement Management Office of Paracelsus Clinics. "This digital
transformation will help us to better interlink outpatient,
inpatient and rehabilitation at home.”
Artificial intelligence (AI) in leading-edge researchOne
of the intended lighthouse projects planned by Paracelsus and
Philips will include installation of Philips’ Informatics AI
Research Suite (IntelliSpace Discovery) in the Paracelsus Elena
Clinic in Kassel – one of Germany’s leading clinics for the
treatment of patients with Parkinson's disease and related movement
disorders. Paracelsus intends to use the AI capabilities of
Philips’ Informatics AI Research Suite (IntelliSpace Discovery) to
further advance the internationally recognized cutting-edge
research carried out by the clinic so that new findings on
neurodegenerative diseases find their way into clinical care.
Scientists can use the AI research platform to develop their own
machine learning algorithms for specific questions. In addition,
Philips will equip the clinic with innovative MR technology to
support diagnosis and treatment in acute neurology care.
Standardization – key to cost efficiencyA team of
consultants from Philips' Healthcare Transformation Services
department, together with representatives from Paracelsus, have
already initiated an optimization project for ultrasound imaging.
Starting with a precise analysis of the current inventory,
diagnostic capabilities, and the competitive environment at the
Paracelsus Henstedt-Ulzburg, Reichenbach and Zwickau clinics, the
team will develop recommendations for needs-based solutions with
uniform operator interfaces. Where it involves ultrasound, the aim
is to improve the level of ultrasound probe compatibility.
Improvement through proactive maintenance and performance
measurement and analysisHospitals must be able to rely on
medical technology always being ready for use. To ensure maximum
availability, Philips will not only take responsibility for
servicing its own technology at Paracelsus, but also that of third
parties. Through a remote service that employs predictive
analytics, potential issues can be identified and solved before
downtime occurs.
Paracelsus also intends to leverage Philips’ Operational
Informatics (PerformanceBridge) to gain deep insights into the
performance and utilization of its imaging solutions. The
solution’s enterprise-wide workflow tools enables modality-specific
analyzes as well as in-house and cross-company comparisons,
allowing potential improvements to be identified and operational
performance increased.
For further information, please contact:
Joost MalthaPhilips Global Press OfficeTel: +31 6 10 55
8116E-mail: joost.maltha@philips.com
Kerstin ZimmermannPhilips DACHMobil: +49 (0) 171/81 80
186E-mail: kerstin.zimmermann@philips.com
Dirten von SchmelingParacelsus-Kliniken Deutschland GmbH &
Co. KGaA Tel.: + 49 0541 6692 333E-mail:
dirten.vonschmeling@pkd.de
About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA)
is a leading health technology company focused on improving
people's health and enabling better outcomes across the health
continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2019 sales of EUR 19.5 billion and
employs approximately 80,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips Paracelsus partnership
- Philips’ Operational Informatics
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024